It cites a Gallup survey finding 11% of Americans now take a GLP-1, up from 3% in 2024, and explains where compounded versions fit under tighter FDA rules.
Recap by typeshit. Full story at USA Today.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
A short clip from obesity doctor Nadolsky with his three pointers for people about to begin GLP-1 treatment. The details are in the video.
A quick list of foods like eggs, Greek yogurt, salmon, lentils and oats, which he says help with fullness and keeping muscle while losing weight.
Lilly Medical points to newly published results from a double-blind, placebo-controlled phase 3 study of its triple-hormone shot in people with diabetes.
Usual care lost 3.3% in the company-run, non-randomized study of 245 adults, which also reported a bit more muscle kept with coaching and exercise help.
Loading…